---
id: https://w3id.org/caufieldjh/linkml-aop
name: linkml-aop
title: linkml-aop
description: |-
  A LinkML schema for Adverse Outcome Pathways,
  based off AOP-Wiki.
  See also the OntoGPT template at
  https://github.com/monarch-initiative/ontogpt/blob/main/src/ontogpt/templates/adverse_outcome_pathway.yaml
license: BSD-3
see_also:
  - https://caufieldjh.github.io/linkml-aop

prefixes:
  linkml_aop: https://w3id.org/caufieldjh/linkml-aop/
  linkml: https://w3id.org/linkml/
  biolink: https://w3id.org/biolink/
  schema: http://schema.org/
  PATO: http://purl.obolibrary.org/obo/PATO_
  example: https://example.org/
default_prefix: linkml_aop
default_range: string

# Classes

classes:
  AOPathway:
    is_a: NamedEntity
    description: >-
      A representation of an Adverse Outcome Pathway, linking molecular initiating events 
      to adverse outcomes through key events.
    attributes:
      # Examples from AOP:503
      title:
        range: string
        description: >-
          A short title for the adverse outcome pathway, summarizing the key events and
          the adverse outcome.
        examples:
          - value: "Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation"
      short_name:
        range: string
        description: >-
          A name that succinctly summarises the information from the title.
          This name should not exceed 90 characters. 
        examples:
          - value: "Activation of uterine estrogen receptor-alfa, endometrial adenocarcinoma"
      graphical_representation:
        range: string
        description: >-
          A graphical representation of the AOP. This graphic should list all KEs in sequence,
          including the MIE (if known) and AO, and the pair-wise relationships (links or KERs)
          between those KEs.
        examples:
          - value: "https://aopwiki.org/aop-503/diagram"
      handbook_version:
        range: string
        description: >-
          The current version of the Developer's Handbook will be automatically populated into the Handbook
          Version field when a new AOP page is created.
          Authors have the option to switch to a newer (but not older) Handbook version any time thereafter.
        examples:
          - value: "Handbook Version v2.6"
      authors:
        range: string
        multivalued: true
        description: >-
          The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. 
        examples:
          - value: "Barbara Viviani, UniversitaÌ€ degli Studi di Milano, Milan, Italy"
      molecular_initiating_event:
        range: MolecularInitiatingEvent
        description: >-
          A free-text description of the molecular initiating event (MIE) that starts the
          adverse outcome pathway. Includes all details necessary to understand the MIE,
          such as the stressor involved, the biological target, and the biological level
          at which the MIE occurs.
      key_events:
        range: KeyEvent
        multivalued: true
        description: >-
          The sequence of key events (KEs) that link the molecular initiating event to
          an adverse outcome.
      adverse_outcome:
        range: AdverseOutcome
        description: >-
          A list of the final adverse outcome (AO) or outcomes.
          This may be a disease, phenotype, or impact on an organism or population.
        multivalued: true
      # key_event_relationships:
      #   range: KeyEventRelationship
      #   multivalued: true
      #   description: >-
      #     A list of relationships between key events in the pathway.

  MolecularInitiatingEvent:
    is_a: NamedEntity
    description: >-
      The initial interaction between a stressor and a biomolecule that starts the
      adverse outcome pathway. The stressor can be a chemical, physical, or biological agent,
      or may not be known.
    attributes:
      stressor:
        range: Stressor
        description: >-
          The chemical or physical agent that initiates the molecular initiating event.
          In the case of a chemical stressor, this may be referred to as a Chemical
          Initiator (CI). If the stressor is not known, it may be referred to as an
          Unknown Initiator (UI), so the value for this attribute should be "UI".
          Examples: aflatoxin B1, lead, radiation.
    slots:
      - target
      - event_type
      - biological_level
      - short_name

  KeyEvent:
    # is_a: NamedEntity
    description: >-
      A measurable biological change that is essential to the progression of the
      adverse outcome pathway.
    slots:
      - target
      - event_type
      - biological_level
      - short_name
      
  AdverseOutcome:
    # is_a: NamedEntity
    description: >-
      An adverse effect of regulatory significance.
    slots:
      - event_type
      - biological_level
      - short_name
    attributes:
      outcome:
        range: Outcome
        description: >-
          The adverse outcome or effect that results from the key events in the pathway.
      
  # KeyEventRelationship:
  #   is_a: CompoundExpression
  #   description: >-
  #     A scientifically-based relationship between two key events in an AOP
  #   attributes:
  #     upstream_event:
  #       range: NamedEntity
  #       description: >-
  #         The event that occurs earlier in the AOP sequence (can be a molecular initiating event or a key event)
  #     downstream_event:
  #       range: NamedEntity
  #       description: >-
  #         The event that occurs later in the AOP sequence (can be a key event or an adverse outcome)
  #     relationship_type:
  #       range: RelationshipType
  #       description: >-
  #         The type of relationship between the two events
  #     evidence:
  #       range: EvidenceType
  #       description: >-
  #         The type of evidence supporting the relationship
      
  Stressor:
    is_a: NamedEntity
    description: >-
      A chemical, physical, or biological agent that initiates the molecular initiating event.

  BiologicalTarget:
    is_a: NamedEntity
    description: >-
      The biological molecule or structure that is affected by the stressor or key event.
      This may be a gene, protein, or other biomolecule (e.g., PARP1) or a chemical species
      (e.g., reactive oxygen species).

  Outcome:
    is_a: NamedEntity
    description: >-
      The outcome or effect that results from the key events in the pathway.
      This may not include the adverse outcome itself, but rather the
      phenomenon describing the outcome. It may be a disease (e.g., 
      neurodegeneration, cancer, heart failure), a phenotype (e.g.,
      developmental delay, immune response), or a process (e.g.,
      learning and memory, cognitive function, population growth
      rate, mortality).

  CellTerm:
    is_a: NamedEntity

    description: >-
      The cell type or tissue in which the event occurs, if applicable.
      This may be a specific cell type (e.g., hepatocyte, neuron) or a
      general tissue type (e.g., liver, brain).

  OrganTerm:
    is_a: NamedEntity
    description: >-
      The organ in which the event occurs, if applicable.
      This may be a specific organ (e.g., liver, heart) or a general
      organ system (e.g., cardiovascular, respiratory).

# Slots
slots:
  target:
    range: BiologicalTarget
    description: >-
      The biological molecule or structure that participates in the event.
      This may be a gene, protein, or other biomolecule (e.g., PARP1) or a chemical
      species (e.g., reactive oxygen species).
  event_type:
    range: EventTypeEnum
    description: >-
      The type of event. Must be one of the following:
      activation, inhibition, increase, decrease, impairment, agonism, antagonism,
      formation, alkylation, phosphorylation, failure, or occurrence.
      For diseases or phenotypes, the event type is often "increase",
      representing an increase in the severity or prevalence of the condition.
      Occurrence is a general event type that should be used when other
      types do not apply.
  biological_level:
    range: LevelOfBiologicalOrganizationEnum
    description: >-
      The level of biological organization at which the event
      occurs. Must be one of the following: molecular, cellular, tissue, organ,
      organism, individual, or population.
  short_name:
    range: string
    description: >-
      A short name or identifier for the event. This is generally
      a combination of the target and event type, such as "Formation, Pro-mutagenic
      DNA Adducts" or "Increase, reactive oxygen species".
  cell_term:
    range: CellTerm
    description: >-
      The cell type or tissue in which the event occurs, if applicable.
      This may be a specific cell type (e.g., hepatocyte, neuron) or a
      general tissue type (e.g., liver, brain).
      If not applicable, this can be left blank.
  organ_term:
    range: OrganTerm
    description: >-
      The organ in which the event occurs, if applicable.
      This may be a specific organ (e.g., liver, heart) or a general
      organ system (e.g., cardiovascular, respiratory).
      If not applicable, this can be left blank.

# Enums
enums:
  LevelOfBiologicalOrganizationEnum:
    description: >-
      The level of biological organization at which an event occurs
    permissible_values:
      molecular:
        description: Molecular level events involving interactions with DNA, proteins, etc.
      cellular:
        description: Effects at the level of the cell
        meaning: GO:0009987
      tissue:
        description: Effects at the level of tissues
      organ:
        description: Effects at the level of organs
      organism:
        description: Effects at the level of the whole organism
      individual:
        description: Effects at the individual level, which may include physiological or behavioral changes
      population:
        description: Effects at the population level

  EventTypeEnum:
    description: >-
      The type of event happening at some biological level.
    permissible_values:
      activation:
        description: Activation of a biomolecule by a stressor
      inhibition:
        description: Inhibition of a biomolecule's activity by a stressor
      increase:
        description: Increase in a biomolecule's activity or concentration
      decrease:
        description: Decrease in a biomolecule's activity or concentration
      impairment:
        description: Impairment of a biological function or process
      agonism:
        description: Mechanistic interaction between two biomolecules or processes
      antagonism:
        description: Antagonistic interaction between two biomolecules or processes
      formation:
        description: Formation of a new biomolecule or complex
      alkylation:
        description: Addition of an alkyl group to a biomolecule, often affecting its function
      phosphorylation:
        description: Addition of a phosphate group to a biomolecule, often regulating its activity
      failure:
        description: Failure of a biological process or function
      occurrence:
        description: General occurrence of a biological event without specific details
      
  # RelationshipType:
  #   description: >-
  #     The type of relationship between two key events in an AOP
  #   permissible_values:
  #     direct:
  #       description: Direct relationship where one event leads to another
  #     indirect:
  #       description: Indirect relationship where one event influences another through intermediates
  
  # EvidenceType:
  #   is_a: NamedEntity
  #   description: >-
  #     The type of evidence supporting a key event relationship
  #   permissible_values:
  #     high:
  #       description: Strong scientific evidence from multiple studies
  #     moderate:
  #       description: Good scientific evidence from a smaller number of studies
  #     low:
  #       description: Limited scientific evidence, often from indirect studies
